• Immunogenicity Assessment

    • Therapeutic In Silico Services
      • ISPRIâ„¢ Website
      • ISPRI Downselectâ„¢
      • ISPRI Quantifyâ„¢
      • ISPRI Analyzeâ„¢
      • ISPRI Evaluateâ„¢
      • ISPRI-HCPâ„¢
      • ISPRI Designâ„¢
      • PANDA® Screening
    • Vaccine In Silico Services
      • iVAXâ„¢
      • EpiCCâ„¢
      • Ancer®
      • PreVAXâ„¢
    • Lab Services
      • HLA Binding Assay
      • Naive CD4+ T Cell Assay
      • Innate Assay
    • Consulting Services
  • About Us
    • Leadership
    • Careers
  • Partner
  • Press
    • News
    • Events
    • Publications
    • Blog
  • Contact Us
H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans

H1N1 G4 swine influenza T cell epitope analysis in swine and human vaccines and circulating strains uncovers potential risk to swine and humans

by Elena Iemma | Oct 26, 2022

Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Plasmodium falciparum Strains

Bridging Computational Vaccinology and Vaccine Development Through Systematic Identification, Characterization, and Downselection of Conserved and Variable Circumsporozoite Protein CD4 T Cell Epitopes From Diverse Plasmodium falciparum Strains

by Elena Iemma | Jun 8, 2021

Predicting Immunogenicity of Vaccines Using EpiCC

Predicting Immunogenicity of Vaccines Using EpiCC

by Annie De Groot | Aug 21, 2019

SWINE_IAV_IVIS2019_POSTER_v9_final_13Aug
Highly Conserved Influenza T Cell Epitopes Induce Broadly Protective Immunity

Highly Conserved Influenza T Cell Epitopes Induce Broadly Protective Immunity

by Annie De Groot | Jul 23, 2019

Highly Conserved Influenza T Cell Epitopes Induce Broadly Protective Immunity
A Prime-Boost Concept Using a T-cell Epitope-driven DNA Vaccine Followed by a Whole Virus Vaccine Effectively Protected Pigs in the Pandemic H1N1 Pig Challenge Model

A Prime-Boost Concept Using a T-cell Epitope-driven DNA Vaccine Followed by a Whole Virus Vaccine Effectively Protected Pigs in the Pandemic H1N1 Pig Challenge Model

by Annie De Groot | Jul 3, 2019

2019 Using a T-Cell Epitope-Driven DNA Vaccine Followed by a Whole Virus Vaccine Protected Pigs in H1N1
« Older Entries

Recent Posts

  • The Platinum Vaccine & Change is Good!
  • EpiVax Appoints Dr. Vibha Jawa to Lead Scientific Strategy as CSO
  • The Amsterdam Immunogenicity & Tolerance Seminar: 2025
  • The Westin Immunogenicity Seminar
  • Is “Artificial” Intelligence an Option for your ADA ?

Recent Comments

No comments to show.

Join our newsletter

Stay up to date with EpiVax and greater industry news, events, and technological advancements with this monthly update written by EpiVax co-founder and CMO, Dr. Annie De Groot.

Explore

Therapeutic In Silico Services

Vaccine In Silico Services

Lab Services

Consulting

LinkedIn

About Us

Careers

Partner

News

Events

Publications

Contact Us

We use cookies to ensure that we give you the best experience on our website. By clicking 'accept', you consent to our use of cookies.AcceptDecline